People channel feed

Ser­no­va chair re­signs fol­low­ing in­sid­er trad­ing in­dict­ment over No­var­tis-Chi­nook deal

Last month
Law

Bound­less Bio changes plans for can­cer drug af­ter tox­i­c­i­ty is­sues

Last month
R&D

Prothena’s amy­loi­do­sis drug flops again, spend­ing and staff cuts are on the way

Last month
R&D

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

Last month
FDA+

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

Last month

Ex­clu­sive: Weight loss start­up Cal­i­brate swaps CEOs in lat­est lead­er­ship shake­up

Last month
Startups
Health Tech

Prime Med­i­cine side­lines on­ly clin­i­cal pro­gram, re­places CEO and lays off some staff

Last month
R&D
Cell/Gene Tx

Up­dat­ed: No­vo Nordisk CEO to step down amid stock de­cline, time­line for suc­ces­sor un­known

Last month
Pharma

Bris­tol My­ers CEO says Amer­i­ca’s bio­phar­ma pole po­si­tion is not guar­an­teed

Last month
Pharma

Unit­ed­Health Group CEO An­drew Wit­ty steps down

Last month
Health Tech

Up­dat­ed: To spin off or not to spin off? Gala­pa­gos backpedals on sep­a­ra­tion plans, CEO Paul Stof­fels ex­its ear­ly

Last month
Cell/Gene Tx

Bay­er starts 2025 by cut­ting 2,000 jobs as it homes in on year-end re­haul tar­get

Last month
Pharma

AI-fo­cused biotech in­sitro cuts 22% of staff, cit­ing 'tu­mul­tuous mar­ket'

2 months ago
AI

Blood can­cer biotech Vor Bio ends clin­i­cal work, lays off 95% of staff

2 months ago

Eu­rope pledges €500M to at­tract glob­al sci­ence tal­ent

2 months ago
Pharma

Ex­clu­sive: Degra­da­tion start­up rais­es $39M for piv­ot to PRO­TACs and clin­i­cal en­try

2 months ago
Financing
Startups

Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

2 months ago
Pharma

Bris­tol My­ers to close cell ther­a­py site in Illi­nois as part of on­go­ing cost cuts

2 months ago
Cell/Gene Tx
Manufacturing

Ex­its con­tin­ue at FDA, as more staff in drug of­fice fol­low fired col­leagues out the door

2 months ago
FDA+

The End­points Slack in­ter­view: Arc In­sti­tute's Patrick Hsu on in­vest­ing, AI and new ways of re­search

2 months ago
AI

Oc­ta­gon Ther­a­peu­tics shuts down af­ter 'un­re­solved bi­ol­o­gy ques­tion­s'

2 months ago
Startups

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

2 months ago

Cari­bou lays off 32% of staff, cuts lu­pus cell ther­a­py pro­gram be­fore first pa­tient

2 months ago
R&D
Cell/Gene Tx

As­traZeneca CEO says Eu­rope is 'falling be­hind' on R&D and man­u­fac­tur­ing in­vest­ments

2 months ago
Pharma
First page Previous page 12345 Next page Last page
A service from the Financial Times